BIOMAT Database Logo BIOMAT Database Logo

[Alcohol elimination during beta adrenergic receptor blockade]. 1978

O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Cardiopulmonary function during adrenergic beta receptor blockade.
January 1965, Cor et vasa,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Adrenergic beta-receptor blockade in hyperthyroidism.
October 1975, British journal of clinical pharmacology,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Perspectives in adrenergic beta-receptor blockade.
January 1969, Clinical pharmacology and therapeutics,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
[Smoking and beta adrenergic receptor blockade].
February 1980, Ugeskrift for laeger,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Effects of beta-adrenergic receptor blockade on glycogenolysis during exercise.
September 1982, Journal of applied physiology: respiratory, environmental and exercise physiology,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Myocardial function during beta-adrenergic blockade.
January 1969, Israel journal of medical sciences,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Beta-adrenergic blockade during severe ischemia.
December 2002, Journal of cardiothoracic and vascular anesthesia,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
BETA-ADRENERGIC RECEPTOR BLOCKADE IN CARDIAC ARRHYTHMIAS.
November 1963, British medical journal,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Adrenergic beta-receptor blockade and anaerobic metabolism.
August 1966, Nature,
O Hartling, and T L Svendsen, and I Jørgensen, and J Trap-Jensen
Beta-adrenergic receptor blockade and renal function.
February 1976, American heart journal,
Copied contents to your clipboard!